BlinatumomabDevelopment of drug resistance: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2021年 / 1847卷 / 1期

关键词：

D O I：

10.1007/s40278-021-92658-2

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：101 / 101

相关论文

共 50 条

[21] CrizotinibAcquired drug resistance: case report
Reactions Weekly, 2023, 1958 (1) : 167 - 167
[22] MeropenemAcquired drug resistance: case report
Reactions Weekly, 2021, 1839 (1) : 184 - 184
[23] PralsetinibAcquired drug resistance : case report
Reactions Weekly, 2024, 2035 (1) : 426 - 426
[24] CeftazidimeAcquired drug resistance: case report
Reactions Weekly, 2025, 2042 (1) : 111 - 111
[25] GefitinibAcquired drug resistance: case report
Reactions Weekly, 2020, 1833 (1) : 185 - 185
[26] GefitinibAcquired drug resistance: case report
Reactions Weekly, 2021, 1866 (1) : 187 - 187
[27] TemozolomideHypermutagenesis and drug resistance: case report
Reactions Weekly, 2021, 1851 (1) : 341 - 341
[28] InfliximabDevelopment of drug resistance: case report
Reactions Weekly, 2021, 1847 (1) : 244 - 244
[29] BedaquilineEmergence of drug resistance: case report
Reactions Weekly, 2019, 1777 (1) : 52 - 52
[30] KanamycinAcquired drug resistance: case report
Reactions Weekly, 2019, 1765 (1) : 209 - 209

← 1 2 3 4 5 →